OUTERLINE: AIRmail: Vollering Wins Giro, Dauphiné Evolves & Olympic Pay Debate

As the glow of the Giro d’Italia Women fades and cycling turns toward the Tour de France, the sport enters its strange June intermission – a month defined by altitude camps, tune-up races and shifting priorities.

This week’s AIRmail looks at Demi Vollering’s dramatic Women’s Giro victory, the changing role of the Dauphiné and Tour de Suisse, why the World Cup is facing growing logistical concerns, the debate over whether Olympic athletes deserve compensation, and what the Enhanced Games could mean for the future of sport and public health.

Analysis, Insight, and Reflections from The Outer Line.

# Catch up on pro cycling – and its context within the broader world of sports – with AIRmail … Analysis, Insight and Reflections from The Outer Line. You can subscribe to AIRmail here, and check out The Outer Line’s extensive library of articles on the governance and economics of cycling here. #

Key Takeaways:

● Vollering Takes Women’s Giro

● Evolving Dauphine and Tour de Suisse Events Up Next for the Men

● World Cup Gets Underway

● Final Thoughts on the “Enhanced Games”

● Coventry: “No Pay for Olympic Athletes”

Demi Vollering left it to the final kilometers of the women’s Giro d’Italia to author another superb stage race victory. Anna van der Breggen was poised to cap her comeback with a hard-earned fifth victory in the Giro, and staked her campaign with a win in the stage 4 uphill time trial win and a commanding lead of over one minute. She defended strongly on the stage 5 and 8 mountaintop finishes, ceding just a single second and time bonuses right behind stage winner Vollering. Despite stage 8 being shortened to finish on Colle de Finistre instead of Sestrieres, it may have been one climb too many for Van der Breggen and her SDWorx-Protime team. Canyon’s Antonia Niedermayer was in a dangerous break on stage 9 and in the virtual lead when FDJ-Suez’s Vollering and teammate Lauren Dickson finally turned the screws, isolating Van der Breggen from team support. Vollering surged ahead on the final climb, connected with the breakaway, and put over two minutes into Van der Breggen to win the overall. As we discussed in recent AIRmail editions, the strength of both the FDJ and SDWorx teams is becoming a clear differentiator in the women’s week-plus tours, with Vollering’s squad markedly improving over the past two seasons to support her while SDWorx has seemingly lost its edge. For all the talk that women’s races can only survive when run right after men’s events on the same schedule, this Giro easily carried its weight and proved that women’s pro cycling is setting a new competitive standard for the sport.

Vollering attacks van der Breggen on stage 9 of the 2026 Giro Women.

Pro road cycling has officially entered its June Gloom interregnum – the muted pause between the first two Grand Tours of the season. Riders and teams have disappeared into secluded high altitude training camps to gain form for July’s Tour de France as the Giro’s pink jersey afterglow fades and interim preparation races get underway. But the sport’s two key pre-Tour tune-ups have been somewhat blunted – from changes in team priorities and calendar crowding concerns. First, ASO’s marquee Tour preparation event, the rebranded Tour Auvergne-Rhône-Alpes Dauphiné, now reflects the organizer’s partnership with a dozen regional government departments. Read plainly, it’s a naming rights deal, and however awkward the new name sounds to anyone who grew up calling the race the Dauphiné – or before that the Dauphiné Libéré – the race itself remains exactly what it has always been: eight days of racing, mountainous terrain and the closest thing the calendar has to a Tour de France dress rehearsal.

Meanwhile, the Dauphiné/Auvergne’s rival, the historic Tour de Suisse, highlights the struggles of an independent race in an era of consolidation. The 89th edition of the race has been reduced from eight days to five (and down from 11 stages in 1986) – a restructuring geared to making the race more appealing to Tour de France contenders. That framing is almost certainly accurate, but it also papers over the harder truth; the nearly 100-year-old independently-organized race has quietly conceded its old identity as the sport’s hardest pre-Tour racing block. Flanders Classics, organizers of the Tour of Flanders and much of the cobbled Classics calendar, entered a “strategic partnership” with Tour de Suisse organizer Cycling Unlimited and its innovative fingerprints are already visible. Stages now start and finish in the same location, reducing logistical burden on riders and staff, and creating a more spectator-friendly circuit format. Additionally, executives at Flanders Classics have said they created the 2026 route to keep riders at altitude prior to the Tour de France, a clever twist to accommodate the rise of altitude fanaticism in the pro peloton. For the proud race’s ego, this may be a bit of a concession, but the outcome seems to support the decision as a star-studded field including Tadej Pogačar and Mathieu van der Poel will headline the event.

Tour de Suisse stages now start and finish in the same location

The UCI’s management committee met last week and issued a detailed update on various internal matters. Unfortunately, in terms of the widely-anticipated strategic input and decision-making process which the UCI initiated last February, the organization said only that it had received some 54 responses to its request, and that the results of the process would be discussed in a future meeting, late this year. Given the overall significance that this project could potentially imply for the future of the sport, it is disappointing that it received far less attention in the UCI communique than a new 2.2 race in India, allowable cycling computer sizes, and the banning of front pockets for bike jerseys.

The 2026 World Cup gets underway in North America this week but not without unresolved organizational issues, exorbitant ticket prices, and legitimate safety concerns. A cross-section of headlines over the past two weeks shows that despite four years of planning, this edition might force future hosts to rethink priorities. As noted, ticket prices are higher than ever before, and with FIFA taking a 30% cut of the official resale market, no one is expecting a significant discount to reduce unsold inventory. The high cost is contributing to fans opting to stay home instead of travel, and those who do are beginning to experience the effects of new travel requirements and restrictions. Even teams and their entourages are finding this difficult to navigate, with South Africa’s travel to Mexico delayed and the Iranian team moving its base to Mexico instead of Arizona; a top Somalian FIFA referee was even denied entry into the US to officiate matches, despite FIFA boss Infantino’s earlier assertion that travel would not be a problem. But security has taken center stage as many U.S. venues are behind schedule due to delays in Federal funding, and on-site gatherings (read: tailgating parties) will not be permitted. Mexico has made massive investments to reinforce security as well. The success or failure of any venue security measures and overall strategies could inform other major sporting events in the future, from the upcoming Los Angeles 2028 Olympics to pro cycling’s Monuments and Grand Tours where close fan proximity and limited on-course controls have been a perpetual safety concern.

As the timeline to the 2028 Los Angeles summer Olympics ticks down, so does the heartbeat for many sports which may be cut ahead of the 2032 Brisbane games. According to reports, there are currently 36 sports on the docket for Los Angeles, an increase from the 26 competed in London in 2012. While some hail this as progress, other observers have pointed out that the increased cost of logistics and purpose-built facilities – such as for Modern Pentathlon and Canoe Slalom – have outstripped the value and sustainability of those events. While nothing will change in the short-term, a recent meeting of the summer Olympics oversight group noted that there will be three new sports in LA (Skateboarding, Surf, and Sport Climbing) that will dilute the situation – and three more demonstration events (Flag Football, Squash, Lacrosse) that will be contested for future medal status. Unfortunately, Cyclocross will not be part of that equation as it has already been cut from the 2030 Winter Games as a demonstration sport. But road cycling can at least take heart that it is at the center of every Olympics broadcast effort: the big reveal for the LA course route should be coming soon.

The Olympics were also in the news last week, when IOC President Kirsty Coventry publicly stated that she didn’t believe Olympic athletes should be paid. In the current environment – see our recent stories on college NIL payments and the “Enhanced Games,” etc. – this went over like the proverbial lead balloon. Instead, Coventry said, Olympic athletes should be happy that they “get beautiful venues, beautiful villages and a beautiful experience…” One athlete pointed out that it is difficult to pay mortgages with memories of performing in the Olympics. Although most Olympic athletes receive some kind of state support or in some cases, private corporate sponsorship, many live on the economic edge. Some countries pay handsome bonuses – up to $1 million – for gold medals, while other countries, like Canada, support their athletes to the tune of just $20,000 a year, or less. A few sports, like track and field, have tried to put systems in place to pay their athletes, but thus far the record has been spotty and very different between different sports. It seems clear that with everything else going on in international sports today, this situation will eventually have to change.

A bookend topic regarding the recently concluded Enhanced Games is its potential negative impacts on the U.S. and other health care systems. Use and abuse of medications and under-regulated substances like peptides for personal and sports enhancement is becoming a quiet epidemic. Similar to the impact of drug addiction, the true scope of usage can only be roughly estimated, due to the private nature of self administration and under-diagnosed body image psychological concerns. While drug addiction has immediate visibility due to overdose deaths, criminality, and long-term social impacts, PED abuse is less easy to detect and can cause progressively debilitating and potentially life threatening health conditions. In turn, this can strain health provider systems and bankrupt the affected individuals due to uninsured diagnoses. For example, anabolic substances can improve lean muscle mass for someone looking to transform their physique, but those same effects can trigger underlying health concerns or cause existing ones to accelerate – precisely why approved testosterone and estrogen hormone replacement therapies are carefully monitored to minimize risks like blood clots and cardiovascular disease.

The Enhanced Games and its core business of peddling personal enhancement products may be here to stay, but the outcome doesn’t have to be entirely negative. There is a broader opportunity, wherein the healthcare industry can begin to standardize personal enhancement therapies and products within a given set of accepted protocols – a kind of “harm reduction” strategy. The Enhanced Games could try to coordinate care between its consumer platform and private health plans via identification of pre-existing risk factors, and offer coverage premiums for adverse PED side effects. As a counterpoint, major healthcare providers have a blind spot for PED health risk factors. Finally quantifying those impacts as a public health issue could threaten the now publicly-traded Enhanced company if significant increases in related illnesses add to insurance rate hikes and coverage uncertainties. That risk can be summed up in one detail that almost flew under the radar: the athletes who were “treated” for the Enhanced Games did so in sequestration for several months at a medical facility in the United Arab Emirates – effectively undergoing novel trials in a medical environment outside of U.S. health agency jurisdiction.